His primary areas of study are Immunology, Immune system, Pathology, Autoimmunity and Interleukin 12. All of his Immunology and Interleukin 21, Innate lymphoid cell, Innate immune system, Myelin oligodendrocyte glycoprotein and Microglia investigations are sub-components of the entire Immunology study. His work is dedicated to discovering how Immune system, Myelin are connected with Cell, Interleukin 18 and Autoantibody and other disciplines.
When carried out as part of a general Pathology research project, his work on Lesion is frequently linked to work in Glial fibrillary acidic protein, therefore connecting diverse disciplines of study. His Autoimmunity research incorporates elements of Autoimmune disease, Cytokine, Pancreas and Uterus. His Cytokine research incorporates themes from Myasthenia gravis, Acetylcholine receptor and FOXP3.
Fu-Dong Shi spends much of his time researching Immunology, Immune system, Neuromyelitis optica, Pathology and Internal medicine. His Myasthenia gravis, Cytokine, Experimental autoimmune encephalomyelitis, Autoimmunity and Autoimmune disease investigations are all subjects of Immunology research. He has researched Autoimmunity in several fields, including IL-2 receptor and Antigen.
His Immune system research includes elements of Interleukin 12 and Nicotine. His work deals with themes such as Neuromyelitis Optica Spectrum Disorders, Brain ischemia and Neurology, which intersect with Pathology. His biological study spans a wide range of topics, including Endocrinology, Rituximab, Cardiology, Gastroenterology and Polysomnography.
His primary areas of investigation include Neuromyelitis optica, Immunology, Pathology, Inflammation and Brain ischemia. The various areas that Fu-Dong Shi examines in his Neuromyelitis optica study include Aquaporin 4, Central nervous system, Grey matter, Spectrum disorder and Spinal cord. His Immunology research is multidisciplinary, incorporating perspectives in Receptor and Intracerebral hemorrhage.
His research in Pathology intersects with topics in White matter, Multiple sclerosis, Neurology and Ischemia. Fu-Dong Shi combines subjects such as Encephalomyelitis, Cytokine and Pathogenesis with his study of Inflammation. His work in Brain ischemia tackles topics such as Pharmacology which are related to areas like Fingolimod, Malondialdehyde, Dimethyl fumarate and Reperfusion injury.
His scientific interests lie mostly in Inflammation, Brain ischemia, Pathology, Immunology and Immune system. His Inflammation research includes themes of Neurology, Neuroscience and Autoimmunity. His studies deal with areas such as Reperfusion injury, Dimethyl fumarate, Anesthesia and Pharmacology as well as Brain ischemia.
His Pathology study combines topics from a wide range of disciplines, such as Cellular immunity and Interleukin 15. The Immunology study combines topics in areas such as Receptor, Follicular phase and Cholinergic. The concepts of his Immune system study are interwoven with issues in Stroke, Interleukin 12 and Choline acetyltransferase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Organ-specific features of natural killer cells
Fu-Dong Shi;Fu-Dong Shi;Hans-Gustaf Ljunggren;Antonio La Cava;Luc Van Kaer.
Nature Reviews Immunology (2011)
Global brain inflammation in stroke.
Kaibin Shi;De-Cai Tian;Zhi-Guo Li;Andrew F Ducruet.
Lancet Neurology (2019)
Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.
Ying Fu;Junwei Hao;Ningnannan Zhang;Li Ren.
JAMA Neurology (2014)
Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.
Zilong Zhu;Ying Fu;Decai Tian;Na Sun.
IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells
Fu-Dong Shi;Fu-Dong Shi;Kiyoshi Takeda;Shizuo Akira;Nora Sarvetnick.
Journal of Immunology (2000)
Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.
Junwei Hao;Ruolan Liu;Wenhua Piao;Qinghua Zhou.
Journal of Experimental Medicine (2010)
Natural killer cells determine the outcome of B cell–mediated autoimmunity
Shi Fd;Shi Fd;Wang Hb;Li H;Hong S.
Nature Immunology (2000)
Impact of an immune modulator fingolimod on acute ischemic stroke.
Ying Fu;Ningnannan Zhang;Li Ren;Yaping Yan.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
Amit Bar-Or;Timothy Vollmer;Jack Antel;Douglas L. Arnold.
JAMA Neurology (2007)
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
Timothy L. Vollmer;Ruolan Liu;Mary Price;Susan Rhodes.
Journal of Immunology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: